Radnostix, Inc.
OTC: INIS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Shahe Bagerdjian
- Employees
- 41
- Headquarters
- Idaho Falls, United States
- IPO year
- 1997
- Market cap
- $40.7M
- Website
- https://radnostix.com
Loading INIS…
Loading profile data…Frequently asked questions about INIS
What does Radnostix, Inc. (INIS) do?
Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobal...
Where does INIS trade?
Radnostix, Inc. (INIS) trades on the Other OTC.
What sector is INIS in?
Radnostix, Inc. (INIS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Radnostix, Inc.?
Shahe Bagerdjian is the chief executive officer of Radnostix, Inc. (INIS).
Where is Radnostix, Inc. headquartered?
Radnostix, Inc. is headquartered in United States.
Does INIS pay a dividend?
Radnostix, Inc. (INIS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INIS go public?
Radnostix, Inc. (INIS) completed its initial public offering in 1997.